InvestorsHub Logo
Followers 138
Posts 23400
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Monday, 01/15/2024 12:39:49 PM

Monday, January 15, 2024 12:39:49 PM

Post# of 464813
How Roche aims to change the 'standard of care'

On dealmaking, Graham notes Roche pursues "groundbreaking science" that can "materially change the standard of care" for high unmet-need diseases. She stresses they remain open across therapeutic areas to back advances that drive health forward.



https://finance.yahoo.com/video/roche-aims-change-standard-care-172623020.html

I am absolutely certain that Roche is interested in partnering with or buying Anavex Life Sciences or licensing Blarcamesine from Anavex.

🇺🇲🇺🇦🇮🇱

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News